Description
Latin name
Magnelis B6
release form
film-coated tablets
Packing
90 pcs.
Pharmacological action
Magnelis B6 – a drug that replenishes the deficiency of magnesium in the body.
Indications
Established magnesium deficiency, isolated or associated with other deficient conditions.
Contraindications
Hypersensitivity to the components of the drug
severe renal failure (CC less than 30 ml / min)
phenylketonuria
children under 6 years of age.
Caution should be used in patients with moderate renal failure, as there is a risk of developing hypermagnesemia.
Use during pregnancy and lactation
Clinical experience has not revealed a fetotoxic or teratogenic effect of the drug.
Magnelis B6 can be used during pregnancy only as directed by a doctor.
Magnesium penetrates excreted in breast milk.
Use of the drug during lactation and breastfeeding should be avoided.
Composition of
1 tablet contains:
active substances:
magnesium lactate dihydrate – 470 mg (in terms of Mg2 + – 48 mg)
pyridoxine hydrochloride – 5 mg
auxiliary components (core):
mg – 27.4 mg
magnesium stearate – 6.8 mg
talc – 6.8 mg
carmellose sodium – 34 mg
acacia gum – 25 mg
collidone SR (polyvinyl acetate – 80% povidone – 19% sodium lauryl sulfate – 0.8 % silicon dioxide – 0, 2%) – 34 mg
shell:
talc – 15 mg
sucrose – 166.7 mg
titanium dioxide – 9 mg
gelatin – 0.9 mg
beeswax – 0.4 mg
acacia gum – 4 mg
kaolin – 54 mg.
Dosage and Administration
Adults are advised to prescribe 6-8 tablets per day.
Children over 6 years of age (weighing more than 20 kg) – 4-6 tablets per day.
The daily dose should be divided into 2-3 doses.
Treatment should be discontinued after normalizing the concentration of magnesium in the blood.
Magnelis B6 should be taken with meals with a glass of water.
Side effects
From the digestive tract: abdominal pain, constipation, nausea, vomiting, flatulence.
Allergic reactions: allergic reactions to the components of the drug are possible.
Drug Interactions
The simultaneous use of drugs containing phosphates or calcium salts can significantly reduce the absorption of magnesium in the gastrointestinal tract.
Magnesium preparations reduce the absorption of tetracycline, it is recommended to share the intake ofquiet preparations at three-hour intervals.
Magnesium weakens the action of oral thrombolytic agents, reduces the absorption of iron.
Vitamin B6 inhibits levodopa activity.
Overdose
Symptoms: drop in blood pressure, nausea, vomiting, slowing of reflexes, anuria, respiratory depression, coma, cardiac arrest.
Treatment: rehydration, forced diuresis. Renal insufficiency requires hemodialysis or peritoneal dialysis.
Storage Conditions
In a dark place at a temperature not exceeding 25 ° C.
Shelf life
2 years.
dosage form
tablets
Indications
Indications
From cramping LCD T, From insomnia, From neurosis
Pharmstandard-Ufafaita, Russia
